Literature DB >> 7694191

Spinal projections of cat primary afferent fibers innervating lumbar facet joints and multifidus muscle.

R G Gillette1, R C Kramis, W J Roberts.   

Abstract

The spinal projections of small-caliber (presumably nociceptive) afferents arising from lumbar spinal joints and muscles were examined using anterograde transport of WGA-HRP. Injections of WGA-HRP into these structures gave rise to similar, rostro-caudally extensive patterns of spinal labeling indicating that many afferents innervating one facet joint or paraspinal muscle terminate bilaterally in laminae I-II, V-VIII, and X of the lumbar, sacral, and thoracic spinal cord. These diffuse patterns of terminal arborization are reminiscent of visceral input and contrast with the more restricted unilateral terminal fields reported for afferents innervating more distal hindlimb tissues.

Mesh:

Substances:

Year:  1993        PMID: 7694191     DOI: 10.1016/0304-3940(93)90644-z

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

Review 1.  Influence of age on the development of pathology.

Authors:  P S Sizer; O Matthijs; V Phelps
Journal:  Curr Rev Pain       Date:  2000

2.  Encapsulated Ruffini-like endings in human lumbar facet joints.

Authors:  F Vandenabeele; J Creemers; I Lambrichts; P Lippens; M Jans
Journal:  J Anat       Date:  1997-11       Impact factor: 2.610

3.  Somatotopic organization of lumbar muscle-innervating neurons in the ventral horn of the rat spinal cord.

Authors:  Yuzuru Takahashi; Seiji Ohtori; Kazuhisa Takahashi
Journal:  J Anat       Date:  2010-01-28       Impact factor: 2.610

4.  What is different about spinal pain?

Authors:  Howard Vernon
Journal:  Chiropr Man Therap       Date:  2012-07-05

5.  Differences in Epidural Pathology between Cervical and Thoracolumbar Intervertebral Disk Extrusions in Dogs.

Authors:  L Züger; A Fadda; A Oevermann; F Forterre; M Vandevelde; D Henke
Journal:  J Vet Intern Med       Date:  2017-11-30       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.